16 doctors from Middle East join CGBio’s clinical training event in Seoul

CGBio, a Korean regenerative medicine company, said it successfully hosted the 2025 CGBio Academy Visiting Clinician Program (VCP) in Seoul, bringing together leading physicians from Saudi Arabia, the United Arab Emirates (UAE), and other Middle Eastern markets.

The three-day event focused on advanced aesthetic procedures using CGBio’s signature collagen stimulator FACETEM, as well as the company’s AiLEENE hyaluronic acid filler and LUXX lifting threads.

The VCP, CGBio’s flagship educational initiative for international healthcare professionals, aims to deepen understanding of the company’s products and enhance practical skills while expanding global recognition.

This year’s program welcomed 16 clinicians from key Middle Eastern countries alongside representatives from CGBio’s regional partner, Vitateck.

The event was strategically designed to capture the fast-growing demand for aesthetic procedures in the Middle East, where high-income growth and increasing interest in natural, refined facial contouring are driving rapid market expansion.

The first day featured an in-depth lecture on facial anatomy for aesthetic procedures by Professor Seung Ho Han of Ewha Womans University College of Medicine. On the second day, Dr. Kim Jong-seo of Kim Jong Seo Plastic Surgery presented combination therapies using diluted calcium hydroxylapatite (CaHA) for acne scar treatment, followed by a live demonstration.

The final day included a lecture and live procedure by Dr. Choi Moon-sub of Grace Plastic Surgery, showcasing advanced techniques using HA fillers and lifting threads.

Throughout the program, participants received hands-on training in procedures incorporating FACETEM, AiLEENE, and LUXX, and also toured CGBio’s S-Campus production facility to observe manufacturing processes and quality control systems.

Among the showcased products, FACETEM—a collagen stimulator formulated with biocompatible CaHA—drew the most attention for its durability and collagen-generating properties. AiLEENE, crafted with high-purity hyaluronic acid, offers enhanced safety and longevity, while LUXX, made from absorbable PDO (polydioxanone), supports non-surgical facial lifting and contouring.

“The VCP program provided a meaningful platform to engage deeply with Middle Eastern clinicians, allowing us to demonstrate the safety and efficacy of FACETEM and our broader aesthetic portfolio,” CGBio CEO Yu Hyun-seung said. “We are committed to accelerating our expansion in the rapidly growing Middle Eastern aesthetic market by strengthening the competitiveness of our products.”